학술논문

Feasibility of real-time cell-of-origin subtype identification by gene expression profile in the phase 3 trial of lenalidomide plus R-CHOP vs placebo plus R-CHOP in patients with untreated ABC-type diffuse large B-cell lymphoma (ROBUST).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2016, 34 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755